Last reviewed · How we verify

NCT02316236: DEALS

Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery

Completed NA Last updated 26 May 2022
What this trial tests

NA trial testing dexmedetomidine in Anesthesia in 66 participants. Completed in 13 August 2015.

Timeline
10 December 2014
Primary endpoint
12 August 2015
13 August 2015

Quick facts

Lead sponsorAir Force Military Medical University, China
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment66
Start date10 December 2014
Primary completion12 August 2015
Estimated completion13 August 2015
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Air Force Military Medical University, China

Who can join

Adults 18 to 65, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is to observe whether dexmedetomidine could reduce agitation during emergence from general anesthesia in patients undergoing retroperitoneal laparoscopic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

Other Air Force Military Medical University, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02316236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing